Literature DB >> 16941029

Urine calcium excretion predicts bone loss in idiopathic hypercalciuria.

J R Asplin1, S Donahue, J Kinder, F L Coe.   

Abstract

Although idiopathic hypercalciuria (IH) is associated with reduced bone mineral density (BMD), no studies to date have identified predictors of BMD change over an extended period of observation. We have studied change in femoral neck and spine BMD z-scores in men and women with IH and stone disease (IHSF) and their first-degree relatives in order to determine the predictive value of commonly made clinical measurements. Urine calcium excretion was inversely correlated with change in femoral neck z-score over 3 years, and marginally correlated with fall in spine z-score. Markers of bone turnover, serum calcitriol, and urine measurements of acid-base balance such as ammonium and sulfate had no predictive value, nor did calcium intake assessed using a well-established questionnaire. It would appear that IHSF with the highest 24-h urine calcium excretion rates are at highest risk for loss of femoral neck bone mineral over a 3-year period.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16941029     DOI: 10.1038/sj.ki.5001778

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  27 in total

Review 1.  Bone disease in pediatric idiopathic hypercalciuria.

Authors:  Maria Goretti Moreira Guimarães Penido; Marcelo de Sousa Tavares
Journal:  World J Nephrol       Date:  2012-04-06

2.  Stones, bones, and cardiovascular groans.

Authors:  Eric N Taylor
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-29       Impact factor: 8.237

3.  Relationship between Urinary Calcium and Bone Mineral Density in Patients with Calcium Nephrolithiasis.

Authors:  Khashayar Sakhaee; Naim M Maalouf; John Poindexter; Beverley Adams-Huet; Orson W Moe
Journal:  J Urol       Date:  2017-01-05       Impact factor: 7.450

4.  Calcium and phosphorus regulatory hormones and risk of incident symptomatic kidney stones.

Authors:  Eric N Taylor; Andrew N Hoofnagle; Gary C Curhan
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-26       Impact factor: 8.237

5.  Determinants of osteopenia in male renal-stone-disease patients with idiopathic hypercalciuria.

Authors:  Emmanuel Letavernier; Olivier Traxer; Michel Daudon; Mohammed Tligui; Jérôme Hubert-Brierre; Dominique Guerrot; Aline Sebag; Laurent Baud; Jean-Philippe Haymann
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-24       Impact factor: 8.237

Review 6.  Idiopathic hypercalciuria and bone health.

Authors:  Laura E Ryan; Steven W Ing
Journal:  Curr Osteoporos Rep       Date:  2012-12       Impact factor: 5.096

7.  Pediatric primary urolithiasis: Symptoms, medical management and prevention strategies.

Authors:  Maria Goretti Moreira Guimarães Penido; Marcelo de Sousa Tavares
Journal:  World J Nephrol       Date:  2015-09-06

8.  High dose vitamin D3 attenuates the hypocalciuric effect of thiazide in hypercalciuric rats.

Authors:  Hye Ryoun Jang; Jay Wook Lee; Sejoong Kim; Nam Ju Heo; Jeong Hwan Lee; Hyo Sang Kim; Ji Yong Jung; Yun Kyu Oh; Ki Young Na; Jin Suk Han; Kwon Wook Joo
Journal:  J Korean Med Sci       Date:  2010-08-14       Impact factor: 2.153

9.  Low bone density in children with hypercalciuria and/or nephrolithiasis.

Authors:  Andrew L Schwaderer; Robert Cronin; John D Mahan; Carlton M Bates
Journal:  Pediatr Nephrol       Date:  2008-08-12       Impact factor: 3.714

10.  Bisphosphonates in children with hypercalciuria and reduced bone mineral density.

Authors:  Michael Freundlich; Uri S Alon
Journal:  Pediatr Nephrol       Date:  2008-08-13       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.